ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,905,000 | +1153.7% | 63,537 | +704.3% | 0.05% | +980.0% |
| Q3 2021 | $471,000 | -41.2% | 7,900 | -24.2% | 0.01% | -54.5% |
| Q4 2020 | $801,000 | -37.7% | 10,423 | -39.4% | 0.01% | -54.2% |
| Q3 2020 | $1,286,000 | -57.0% | 17,197 | -73.5% | 0.02% | -82.0% |
| Q3 2018 | $2,991,000 | +5.5% | 65,000 | 0.0% | 0.13% | -13.6% |
| Q2 2018 | $2,834,000 | +377.9% | 65,000 | +333.3% | 0.15% | +250.0% |
| Q1 2018 | $593,000 | – | 15,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |